Insider · CIK 0001351779
Nadav Kidron
ceopresidentofficerdirector
Files at ORMP (ORAMED PHARMACEUTICALS INC.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 24, 2026 | ORMP ORAMED PHARMACEUTICALS INC. | AGrant or award Common Stock | +349,497 | - | - | 3,771,740 | 17 d ago |
| Sep 24, 2026 | ORMP ORAMED PHARMACEUTICALS INC. | AGrant or award Common Stock | +368,765 | - | - | 4,140,505 | 17 d ago |
| Sep 24, 2026 | ORMP ORAMED PHARMACEUTICALS INC. | DDisposition to issuer Stock option (right to buy)derivative | -196,500 | - | - | 0 | 17 d ago |
| Sep 24, 2026 | ORMP ORAMED PHARMACEUTICALS INC. | DDisposition to issuer Stock option (right to buy)derivative | -190,000 | - | - | 0 | 17 d ago |
| Sep 24, 2026 | ORMP ORAMED PHARMACEUTICALS INC. | DDisposition to issuer Stock option (right to buy)derivative | -49,000 | - | - | 0 | 17 d ago |
| Sep 24, 2026 | ORMP ORAMED PHARMACEUTICALS INC. | DDisposition to issuer Stock option (right to buy)derivative | -97,000 | - | - | 0 | 17 d ago |
| Sep 24, 2026 | ORMP ORAMED PHARMACEUTICALS INC. | DDisposition to issuer Stock option (right to buy)derivative | -150,000 | - | - | 0 | 17 d ago |
| Sep 24, 2026 | ORMP ORAMED PHARMACEUTICALS INC. | DDisposition to issuer Stock option (right to buy)derivative | -107,000 | - | - | 0 | 17 d ago |
| Feb 11, 2025 | ORMP ORAMED PHARMACEUTICALS INC. | AGrant or award Common Stock | +141,000 | $0.00 | $0 | 2,400,598 | Feb 11, 2025 |
| Feb 11, 2025 | ORMP ORAMED PHARMACEUTICALS INC. | AGrant or award Common Stock | +186,000 | $0.00 | $0 | 2,586,598 | Feb 11, 2025 |
| Feb 11, 2025 | ORMP ORAMED PHARMACEUTICALS INC. | AGrant or award Common Stock | +100,000 | $0.00 | $0 | 2,686,598 | Feb 11, 2025 |
| Jan 2, 2025 | ORMP ORAMED PHARMACEUTICALS INC. | AGrant or award Common Stock | +433,500 | - | - | 2,259,598 | Jan 6, 2025 |
| Nov 7, 2024 | ORMP ORAMED PHARMACEUTICALS INC. | AGrant or award Common Stock | +45,000 | - | - | 1,826,098 | Nov 8, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.